Mr. Speaker, if we look at the situation in France and the United States, pharmaceutical companies have a legal obligation to clearly report any time there is a shortage of pharmaceutical products. It is mandatory, not voluntary. If there is a drug shortage, companies must clearly report it to governments.
In my opinion, this problem is not uniquely Canadian. It does not stop at any borders; it is a global problem. That is one more reason for this government to fulfill its responsibilities. Indeed, it will be the government that goes before the World Health Assembly to work with the UN and the international institutions in order to really try to understand this problem.
I am not saying that it is a simple problem; not at all. What I am saying is that, so far, the federal government has adopted the position that this does not come under its jurisdiction. I hope I have clearly demonstrated that, from a legal standpoint, from a constitutional standpoint, this is a shared jurisdiction and the federal government does have considerable responsibilities here.